← SynDRA
ACUMAPIMOD
SynDRA canonical compound SYN0040598 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | MAPK14 |
|---|
| Mechanism of action | p38 MAPK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- MAP kinase p38 alpha inhibitor
Drug classes
- Protein Kinase Inhibitors
Cross-references
Synonyms
- Bct-197
- BCT-197
- BCT-197-A2201
- BCT 197
- 2F16KW647L
- acumapimodum
- RefChem:109601
- Acumapimod (BCT-197)
- Acumapimod [INN]
- BCT197
- UNII-2F16KW647L
- MFCD28902244
- Acumapimod (BCT197)?
- ACUMAPIMOD [WHO-DD]
- GTPL9203
- orb1299879
- SCHEMBL1382253
- SCHEMBL29378269
- SCHEMBL29429435
- VGUSQKZDZHAAEE-UHFFFAOYSA-N
- C22H19N5O2
- GLXC-10787
- EX-A1450
- LIB68315
- compound A [WO2013139809]
- AKOS032945000
- CS-6195
- SB18669
- AC-36221
- DA-60800
- HY-16715
- MS-26353
- T7367
- D84042
- F841073
Look up ACUMAPIMOD in the interactive SynDRA portal →